Somerset Therapeutics Private Limited FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection OAI · Feb 21, 2025
  • Last warning letter 2025
Inspections 10 4 OAI
Recalls 5 0 Class I (0%)
Warning letters 3 Latest Sep 4, 2025
510(k) clearances 0 None on file

Somerset Therapeutics Private Limited has 5 FDA recalls, 10 inspections, 0 510(k) clearances and 3 compliance actions on record. FDA has issued 3 warning letters to Somerset Therapeutics Private Limited, the most recent on Sep 4, 2025. FDA has published 1 Form 483 for Somerset Therapeutics Private Limited.

What these totals cover: FDA records filed under the name "Somerset Therapeutics Private Limited". Records filed under related names are not included; see Related names.

Latest recall
D-0398-2026 · Feb 4, 2026 · filed under Somerset Therapeutics
Latest recall under this name
D-0354-2025 · Class II · Mar 21, 2025
Latest inspection
Feb 21, 2025 · OAI

Newer recall under related name Somerset Therapeutics: Feb 4, 2026, D-0398-2026.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls5Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections10Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions3Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Somerset Therapeutics Private Limited's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Somerset Therapeutics Private Limited: FDA inspections per year

2017: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 1 inspection (1 OAI), 1 warning letter, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 1 inspection (1 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 1 inspection (1 OAI), 1 warning letter, 5 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202511150
202400000
202310000
202211000
202100000
202011100
201910000
201800000
201720000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Somerset Therapeutics Private Limited as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Somerset Therapeutics Private Limited yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Somerset Therapeutics Private Limited FDA Warning Letters

3 warning letters from Feb 23, 2012 to Sep 4, 2025.

IssuedSubjectIssuing officeClose-out letter
Sep 4, 2025 · Letter on fda.gov CGMP/Finished Pharmaceuticals/AdulteratedCenter for Drug Evaluation and Research (CDER)
Aug 13, 2020 · Record page
Feb 23, 2012 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Somerset Therapeutics Private Limited Form 483s

1 Form 483 published by FDA.

DateDocumentFEI
Feb 21, 2025 · Document on fda.gov 4833003821988

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

5 recall records on Mar 21, 2025.

NumberClassProductDate
D-0354-2025Class IIMethocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only…Mar 21, 2025
D-0357-2025Class IIHaloperidol Decanoate Injection 100mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset…Mar 21, 2025
D-0356-2025Class IIHaloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset…Mar 21, 2025
D-0358-2025Class IIHaloperidol Decanoate Injection, 100 mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for…Mar 21, 2025
D-0355-2025Class IIHaloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset…Mar 21, 2025

Recent FDA inspections

10 inspections from Mar 31, 2009 to Feb 21, 2025.

DateSiteProductClassificationFEI
Feb 21, 2025Bengaluru, IndiaDrugsOfficial Action Indicated (OAI)3003821988
Oct 27, 2023Bengaluru, IndiaDrugsVoluntary Action Indicated (VAI)3003821988
Apr 4, 2022Bengaluru, IndiaDrugsOfficial Action Indicated (OAI)3003821988
Feb 19, 2020Bengaluru, IndiaDrugsOfficial Action Indicated (OAI)3003821988
Jul 23, 2019Bengaluru, IndiaDrugsVoluntary Action Indicated (VAI)3003821988
Dec 5, 2017Bengaluru, IndiaDrugsVoluntary Action Indicated (VAI)3003821988
Apr 24, 2017Bengaluru, IndiaDrugsNo Action Indicated (NAI)3003821988
Aug 20, 2013Bengaluru, IndiaDrugsVoluntary Action Indicated (VAI)3003821988
Sep 20, 2011Bengaluru, IndiaDrugsOfficial Action Indicated (OAI)3003821988
Mar 31, 2009Bengaluru, IndiaDrugsVoluntary Action Indicated (VAI)3003821988
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 3 compliance actions under Somerset Therapeutics Private Limited: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Sep 4, 2025.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3003821988Bengaluru, India10Feb 21, 2025

Somerset Therapeutics Private Limited and the FDA: common questions

Has Somerset Therapeutics Private Limited received an FDA warning letter?

Yes. FDA has issued 3 warning letters to Somerset Therapeutics Private Limited. The most recent is dated Sep 4, 2025, with the subject "CGMP/Finished Pharmaceuticals/Adulterated".

Has Somerset Therapeutics Private Limited received an FDA Form 483?

FDA has published 1 Form 483 for Somerset Therapeutics Private Limited in its reading room, the most recent dated Feb 21, 2025. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Somerset Therapeutics Private Limited?

The most recent FDA inspection on file ended Feb 21, 2025 at Bengaluru, India and was classified OAI. FDA has 10 inspections of Somerset Therapeutics Private Limited on file, 4 of them classified OAI (official action indicated).

Has Somerset Therapeutics Private Limited had an FDA recall?

Yes. Somerset Therapeutics Private Limited has 5 FDA recalls on record. The most recent under this name started Mar 21, 2025. A newer recall, dated Feb 4, 2026, is filed under the related name Somerset Therapeutics.

Need more than this page shows? Ask about Somerset Therapeutics Private Limited in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.